Comparing AI and doctor teams for stomach, colon, or rectal cancer care
Part of Cancer, Digestive system clinical trials.
This study compares treatment recommendations from a computer system with those from a team of cancer doctors. It may help improve how cancer care decisions are made.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with stomach, colon, or rectal cancer, or your doctors strongly suspect it.
- You are scheduled for a cancer team meeting to decide your next steps in care.
- You are willing to allow your medical information to be used for research.
- You can provide written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is looking at whether artificial intelligence can make treatment decisions as well as a team of cancer experts. If you have colorectal cancer and have been seen by the cancer experts at Peking University Cancer Hospital, your medical records may help answer this question.
This study uses a special artificial intelligence (AI) program to help doctors spot stomach cancer during an upper endoscopy (a camera test of the stomach). It is for people 60 and older who are already scheduled for this test because they have a higher risk of stomach cancer.
This study looks at how doctors use different digital tools, including AI, to plan care for people coming into the hospital. It may help make hospital care safer and better planned.
This study compares how an artificial intelligence system and a team of cancer doctors recommend treatment for rectal cancer. By understanding how well they agree, researchers hope to improve cancer treatment planning.
This trial tests an AI-based platform to help plan the best surgery for people with colon or rectal cancer. It aims to improve decision-making by both doctors and patients.
This trial compares treatment recommendations from large language models (AI) against those from experienced tumor boards for five common cancer types. The goal is to see if AI can help doctors make better decisions.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.